GenMont Biotech Incorporation (3164.TW) TAI

19.10

-0.05(-0.26%)

Updated at September 30 12:09PM

Currency In TWD

Valuation

Market Cap1.75B
Enterprise Value1.76B
P/E Ratio107.27
PEG Ratio-1.79
Price/Sales Ratio4.25
Price/Book Ratio1.35
Enterprise/Revenue4.35
Enterprise/EBITDA19.56

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.1

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue385.37M
Revenue/Share4.42
Gross Profit238.18M
EBITDA140.03M
Net Income57.25M
Diluted EPS0.66

Balance Sheet

Total Cash356.24M
Total Cash/Share4.08
Total Debt107.21M
Total Debt/Equity0.09
Current Ratio4.38
Book Value Per Share15.47

Price History

52-Week Change-17.32
52-Week High23.35
52-Week Low17.2
Moving Average 50 Days20.02
Moving Average 200 Days20.24

Statistics

Average Volume22,699
Shares Outstanding86.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield4.19
Payout Ratio2.78
Last Split Factor11:10
Last Split DateJune 15, 2010